Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BOPH OTCMKTS:NRXGQ NASDAQ:SYRS OTCMKTS:WCUI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOPHBohai Pharmaceuticals Group$0.00$0.00$0.00▼$0.00$20K1.7830,425 shs50,000 shsNRXGQNephroGenex$0.00$0.00▼$0.21$36KN/A26,223 shs2,000 shsSYRSSyros Pharmaceuticals$0.00$0.01$0.00▼$0.10$59K1.31165,329 shs5,203 shsWCUIWellness Center Usa$0.00$0.00▼$0.04$10K4.71N/AN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOPHBohai Pharmaceuticals Group0.00%0.00%0.00%0.00%0.00%NRXGQNephroGenex0.00%0.00%0.00%0.00%0.00%SYRSSyros Pharmaceuticals0.00%+100.00%-33.33%-90.13%-99.86%WCUIWellness Center Usa0.00%0.00%0.00%-81.82%-83.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOPHBohai Pharmaceuticals Group$0.00$0.00$0.00▼$0.00$20K1.7830,425 shs50,000 shsNRXGQNephroGenex$0.00$0.00▼$0.21$36KN/A26,223 shs2,000 shsSYRSSyros Pharmaceuticals$0.00$0.01$0.00▼$0.10$59K1.31165,329 shs5,203 shsWCUIWellness Center Usa$0.00$0.00▼$0.04$10K4.71N/AN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOPHBohai Pharmaceuticals Group0.00%0.00%0.00%0.00%0.00%NRXGQNephroGenex0.00%0.00%0.00%0.00%0.00%SYRSSyros Pharmaceuticals0.00%+100.00%-33.33%-90.13%-99.86%WCUIWellness Center Usa0.00%0.00%0.00%-81.82%-83.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBOPHBohai Pharmaceuticals Group 0.00N/AN/AN/ANRXGQNephroGenex 0.00N/AN/AN/ASYRSSyros Pharmaceuticals 2.00Hold$1.0045,354.55% UpsideWCUIWellness Center Usa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AN/ANRXGQNephroGenexN/AN/AN/AN/AN/AN/ASYRSSyros Pharmaceuticals$386K0.15N/AN/A$0.79 per share0.00WCUIWellness Center Usa$660K0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBOPHBohai Pharmaceuticals GroupN/AN/A0.00∞N/AN/AN/AN/AN/ANRXGQNephroGenexN/AN/A0.00N/AN/AN/AN/AN/AN/ASYRSSyros Pharmaceuticals-$164.57M-$3.03N/AN/AN/AN/A-3,369.56%-97.04%10/29/2025 (Estimated)WCUIWellness Center Usa-$750KN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/ANRXGQNephroGenexN/AN/AN/AN/AN/ASYRSSyros PharmaceuticalsN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBOPHBohai Pharmaceuticals GroupN/AN/AN/ANRXGQNephroGenexN/AN/AN/ASYRSSyros PharmaceuticalsN/A2.252.25WCUIWellness Center UsaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBOPHBohai Pharmaceuticals GroupN/ANRXGQNephroGenexN/ASYRSSyros Pharmaceuticals91.47%WCUIWellness Center Usa0.01%Insider OwnershipCompanyInsider OwnershipBOPHBohai Pharmaceuticals GroupN/ANRXGQNephroGenexN/ASYRSSyros Pharmaceuticals12.26%WCUIWellness Center Usa15.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBOPHBohai Pharmaceuticals GroupN/A19.52 millionN/ANot OptionableNRXGQNephroGenex1,70012.95 millionN/ANot OptionableSYRSSyros Pharmaceuticals12026.83 million23.54 millionOptionableWCUIWellness Center Usa8143.19 million120.71 millionNot OptionableWCUI, NRXGQ, SYRS, and BOPH HeadlinesRecent News About These CompaniesStudent Wellness Center holds first of three trainings on opioid safety and responseSeptember 12 at 6:08 PM | newsrecord.orgNLassen County Office of Education launches New Wellness Center websiteSeptember 11 at 10:29 PM | lassennews.comLNorthwest ISD to open free Student Wellness Center at flagship campusSeptember 11 at 10:29 PM | crosstimbersgazette.comCWellness Center Usa (OTCMKTS:WCUI) and Beauty Health (NASDAQ:SKIN) Financial ContrastSeptember 7, 2025 | americanbankingnews.comRep. Hunschofsky, Sen. Polsky Present $350K in State Funding to Eagles’ Haven Wellness CenterSeptember 3, 2025 | parklandtalk.comPRep. Hunschofsky, Sen. Polsky Present $350K in State Funding to Eagles’ Haven Wellness CenterSeptember 3, 2025 | parklandtalk.comPWellness Expert and Master Injector Natalya Celi Joins Staff at Parkland Medspa & Wellness CenterAugust 28, 2025 | finance.yahoo.comDemolition begins on Norfolk Fitness and Wellness Center Dome to make way for new facilityAugust 7, 2025 | msn.comdidgwalic Wellness Center to host March Against AddictionAugust 1, 2025 | goskagit.comGTribe to celebrate grand opening of Mary L. (Holland) Carson Wellness Center in StilwellAugust 1, 2025 | tahlequahdailypress.comTMall at Wellington Green's makeover continues as local wellness center relocates thereJuly 19, 2025 | ftw.usatoday.comJasper considering funding options for Regional Wellness CenterJuly 19, 2025 | duboiscountyfreepress.comDHealing begins where taboos end at SIU Pelvic Wellness CenterJuly 16, 2025 | nprillinois.orgNRagin Wellness Center offering trauma therapy to young people in SumterJuly 16, 2025 | abccolumbia.comA5 walkouts of mentally ill patients prompt policy reform at Guam Behavioral Health and Wellness CenterJuly 13, 2025 | guampdn.comGForty Fort Parks and Recreation Committee donates to Cancer Wellness Center of NEPAJuly 13, 2025 | timesleader.comTLamar Mental Wellness Center in Augusta aids mental health needsJuly 11, 2025 | msn.comFlagler Schools cut ribbon on new Wellness CenterJuly 9, 2025 | observerlocalnews.comOWest Monroe Honors Local Businesses with “Yard of the Month” Award for Outstanding Beautification to The Wellness CenterJuly 5, 2025 | msn.comAvas Wellness Center and Spa to Anchor a Growing Wellness-Driven Ecosystem in AlibaugJuly 2, 2025 | devdiscourse.comDNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWCUI, NRXGQ, SYRS, and BOPH Company DescriptionsBohai Pharmaceuticals Group OTCMKTS:BOPH$0.0010 0.00 (0.00%) As of 03/11/2019Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.NephroGenex OTCMKTS:NRXGQNephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.Syros Pharmaceuticals NASDAQ:SYRS$0.0022 0.00 (0.00%) As of 09/12/2025 02:07 PM EasternSyros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.Wellness Center Usa OTCMKTS:WCUIWellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
